119th Congress
H.R. 661
MIRACLE Medical Technology Act of 2025
- Introduced
- In committee
- Passed House
- Passed Senate
- To President
- Became law
- Sponsor
- Vern Buchanan(R-FL)
- Introduced
- Jan 23, 2025
- Policy area
- Health
- Committees
- House Committee on Energy and Commerce
- Official text
- Introduced in House · Congress.gov page
Cosponsors (3)
Original cosponsors (2)
- Darren Soto (D-FL)
- Mariannette Miller-Meeks (R-IA)
Added later (1)
- Thomas R. Suozzi (D-NY) · Dec 23, 2025
Summary
Summary by the Congressional Research Service· describes the “Introduced in House” version
Maximizing Israel-U.S. Research Advancement and Collaborative Leadership in Emerging Medical Technology Act of 2025 or the MIRACLE Medical Technology Act of 2025
This bill requires the Department of Health and Human Services (HHS) to implement a program for the United States and Israel to collaborate on developing and delivering health care products and services. The program must include coordinated activities in specified areas, including research and development, use of innovative technology, intellectual property protection, regulatory harmonization, disease prevention, and biological product manufacturing. The bill authorizes HHS to establish a joint United States-Israel Health Care Collaboration Center in the United States to leverage existing expertise for advancing the program’s purposes.
Roll-call votes
No recorded votes on this bill.
Actions
- Jan 23, 2025 · House
Referred to the House Committee on Energy and Commerce. - Jan 23, 2025
Introduced in House